Illinois
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Illinois: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Illinois adheres to the principles established by the U.S. Supreme Court in Association for Molecular Pathology v. Myriad Genetics, Inc. regarding the patentability of naturally occurring genes. The state courts apply these principles when assessing patent claims, particularly in the context of biotechnological inventions.
In Illinois, as with federal law, isolated genes and natural phenomena are not patentable as they are considered products of nature. However, synthetic modifications or innovative methods of using such genes may still be eligible for patent protection.
The Illinois Supreme Court reaffirmed the unpatentability of laws of nature and methods that are essentially natural phenomena.
The court ruled on the non-patentability of abstract ideas, which parallels the principles regarding natural products established in Myriad.
The Court found that certain genetic modifications could be patentable if they confer distinct and substantial utility, aligning with Myriad's teachings.
Illinois law mirrors the federal standard established in the Myriad case, specifically concerning the unpatentability of naturally occurring substances. Both jurisdictions emphasize the necessity of a significant and innovative modification or application to overcome the natural product exclusion.
Understanding the implications of Myriad is essential for the Illinois bar exam, particularly in the context of patent law and biotechnological innovations.